Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiyang Yun

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemiaFrederik Damm, Michael Heuser, Michael Morgan, et al.
Blood|February 22, 2018
Glutaminolysis is a metabolic dependency in FLT3<sup>ITD</sup> acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibitionPaolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis, et al.
Blood|December 28, 2022
HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemiaShuchi Agrawal-Singh, Jaana Bagri, George Giotopoulos, et al.
Annals of Hematology|April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromesFelicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.
The Journal of Experimental Medicine|March 21, 2019
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AMLFaisal Basheer, George Giotopoulos, Eshwar Meduri, et al.
Nature Genetics|September 24, 2021
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expressionHaiyang Yun, Nisha Narayan, Shabana Vohra, et al.
Blood|August 20, 2013
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AMLAnuhar Chaturvedi, Michelle Maria Araujo Cruz, Nidhi Jyotsana, et al.
Cancer Discovery|October 19, 2022
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid LeukemiaFengbiao Zhou, Nesrine Aroua, Yi Liu, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Nature Genetics|May 9, 2018
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programsMalgorzata Gozdecka, Eshwar Meduri, Milena Mazan, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemiaFrederik Damm, Michael Heuser, Michael Morgan, et al.
Blood|February 22, 2018
Glutaminolysis is a metabolic dependency in FLT3<sup>ITD</sup> acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibitionPaolo Gallipoli, George Giotopoulos, Konstantinos Tzelepis, et al.
Blood|December 28, 2022
HOXA9 forms a repressive complex with nuclear matrix-associated protein SAFB to maintain acute myeloid leukemiaShuchi Agrawal-Singh, Jaana Bagri, George Giotopoulos, et al.
Annals of Hematology|April 11, 2012
Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromesFelicitas Thol, Haiyang Yun, Ann-Kathrin Sonntag, et al.
The Journal of Experimental Medicine|March 21, 2019
Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AMLFaisal Basheer, George Giotopoulos, Eshwar Meduri, et al.
Nature Genetics|September 24, 2021
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expressionHaiyang Yun, Nisha Narayan, Shabana Vohra, et al.
Blood|August 20, 2013
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AMLAnuhar Chaturvedi, Michelle Maria Araujo Cruz, Nidhi Jyotsana, et al.
Cancer Discovery|October 19, 2022
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid LeukemiaFengbiao Zhou, Nesrine Aroua, Yi Liu, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Nature Genetics|May 9, 2018
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programsMalgorzata Gozdecka, Eshwar Meduri, Milena Mazan, et al.
Pageof 3